Antibody-drug Conjugates in the Clinic: 

Key Considerations & the Role of Modeling in Expediting Development
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at www.certara.com/

Наука